Literature DB >> 21272639

Comparison of analytical methods to detect instability of etanercept during thermal stress testing.

Andreas van Maarschalkerweerd1, Gert-Jan Wolbink, Steven O Stapel, Wim Jiskoot, Andrea Hawe.   

Abstract

The aim was comparing the capability of a set of analytical methods to detect physical instability (focus on aggregation and structural changes) of etanercept during thermal stress testing as early as possible. Pre-filled syringes of Enbrel® 50mg from three batches were thermally stressed for one week at 50°C. Samples were taken at days 0, 1, 2, 3, 4 and 7, and analyzed with high-performance liquid size exclusion chromatography (HP-SEC), SDS-PAGE gel electrophoresis, dynamic light scattering (DLS), light obscuration, extrinsic fluorescence (Bis-ANS), far-UV circular dichroism (CD) spectroscopy, second derivative UV spectroscopy (UV), and enzyme-linked immunosorbent assay (ELISA). Thermal stress resulted in the formation of small soluble aggregates (HP-SEC, DLS) which were in part covalent (SDS-PAGE), and conformationally changed (Bis-ANS, CD, UV). No significant increase in subvisible particles was detected by light obscuration. An apparent increase in TNF-α binding to etancercept in the stressed formulations was found by ELISA. The three batches were comparable when unstressed, but showed slight differences in aggregation tendency. Bis-ANS fluorescence was most sensitive with respect to early-stage detection of heat-induced instability of etanercept (significant changes already at day 1), followed by HP-SEC (day 2) and DLS (day 3). This points towards a degradation mechanism involving exposure of hydrophobic patches due to partial unfolding followed by aggregation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272639     DOI: 10.1016/j.ejpb.2011.01.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar.

Authors:  Ramin Fazel; Fereidoun Mahboudi; Ehsan Seyedjafari; Soroush Sardari; Behrouz Vaziri
Journal:  Iran J Biotechnol       Date:  2019-12-01       Impact factor: 1.671

2.  Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.

Authors:  M Giulbudagian; G Yealland; S Hönzke; A Edlich; B Geisendörfer; B Kleuser; S Hedtrich; M Calderón
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

3.  Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy.

Authors:  Mengchen An; Mengxiao Shi; Jingjing Su; Yueru Wei; Rongrong Luo; Pengchao Sun; Yongxing Zhao
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.